Brainsway Ltd. ADR (BWAY)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
BrainsWay: Operating Leverage Driving Upside
BrainsWay reported strong earnings in Q2, with growth remaining strong and margins continuing to improve. Growth among enterprise accounts and internationally should ensure BrainsWay continues to perform well, provided that the macro environment remains stable. Neuronetics' decision to merge with Greenbrook TMS seems to support the strength of BrainsWay's business.
Why Brainsway (BWAY) Might be Well Poised for a Surge
Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Brainsway (BWAY) Could Surge 72.29%: Read This Before Placing a Bet
The mean of analysts' price targets for Brainsway (BWAY) points to a 72.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BrainsWay Ltd. (BWAY) Q2 2024 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2024 Earnings Call Transcript August 6, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Steve Lichtman - Oppenheimer Jeffery S.
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold
BrainsWay's (BWAY) latest exclusive multi-year distribution agreement is likely to provide improved patient care in Canada.
BrainsWay (BWAY) to Advance in DEEP TMS for MDD With New Trial
BrainsWay (BWAY) emphasizes the potential of the accelerated protocol, citing previous data suggesting comparable outcomes with traditional, longer protocols.
